SIMON BUELA; Laureano

Patent Applications and Registrations

Patent applications and USPTO patent grants for SIMON BUELA; Laureano.The latest application filed is for "1,3,4-oxadiazole derivatives as histone deacetylase inhibitors".

Company Profile

0.13.20

SIMON BUELA; Laureano - San Sebastian Guipuzcoa
Simon Buela; Laureano - Derio ES
Simon Buela; Laureano - Derio-Vizcaya N/A ES
Simon Buela; Laureano - Vizcaya ES
Simon Buela; Laureano - Guipuzcoa ES
Simon Buela; Laureano - Guip zcoa N/A ES
SIMON BUELA; LAUREANO - BIZKAIA ES
Simon Buela; Laureano - San Sebasian N/A ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,3,4-oxadiazole Derivatives As Histone Deacetylase Inhibitors App 20220213084 - VARA SALAZAR; Yosu Ion ; et al.	2022-07-07
Method to optimize the treatment of patients with biological drugs Grant 10,215,762 - Ruiz Del Agua , et al. Feb	2019-02-26
Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas Grant 9,702,879 - Barneo Serra , et al. July 11, 2	2017-07-11
Method To Optimize The Treatment Of Patients With Biological Drugs App 20170102394 - RUIZ DEL AGUA; AINHOA ; et al.	2017-04-13
STXBP1 overexpressing mouse and its uses in screening of treatments for neuropsychiatric illness Grant 9,267,151 - Guerrero Martinez , et al. February 23, 2	2016-02-23
Prognostic Method App 20160010160 - del Amo; Jokin ; et al.	2016-01-14
Methods And Products For Prognosing The Clinical Evolution, Or Predicting The Recurrence Risk, Of A Papillary Lesion Of The Breast App 20150369808 - FREIRE SALINAS; Francisco Javier ; et al.	2015-12-24
Methods And Products For In Vitro Diagnosis, In Vitro Prognosis And The Development Of Drugs Against Invasive Carcinomas App 20150362496 - Barneo Serra; Luis ; et al.	2015-12-17
Prognostic method Grant 9,109,257 - Amo , et al. August 18, 2	2015-08-18
Biomarkers For Epilepsy App 20140315737 - CARA TERRIBAS; CARLOS ; et al.	2014-10-23
Methods of prognosing a rheumatoid arthritis remission phenotype Grant 8,712,696 - Eguiara , et al. April 29, 2	2014-04-29
Detection of endometrial secretion markers for assessment of endometriosis Grant 8,679,769 - Nagore , et al. March 25, 2	2014-03-25
Method To Optimize The Treatment Of Patients With Biological Drugs App 20130280171 - Ruiz Del Agua; Ainhoa ; et al.	2013-10-24
Genetic Markers For The Prognosis Of Multiple Sclerosis App 20130184167 - Villoslada Diaz; Pablo ; et al.	2013-07-18
Diagnostic method Grant 8,296,073 - Cadaval , et al. October 23, 2	2012-10-23
Methods and products for in vitro genotyping Grant 8,153,363 - Simon Buela , et al. April 10, 2	2012-04-10
Stxbp1 As Psychiatric Biomarker In Murine Model System And Their Uses App 20110268747 - Guerrero Martinez; Maria Jose ; et al.	2011-11-03
In Vitro Methods For Detecting Renal Cancer App 20110098191 - Gomez Roman; Jose Javier ; et al.	2011-04-28
Method And Product For "in Vitro" Genotyping With Applications In Anti-ageing Medicine App 20110045997 - Tejedor Hernandez; Diego ; et al.	2011-02-24
Detection Of Endometrial Secretion Markers For Assessment Of Endometriosis App 20110015087 - Nagore Casas; Daniel ; et al.	2011-01-20
Prognostic method App 20100185429 - Amo; Jokin del ; et al.	2010-07-22
Prognostic Method App 20100087441 - Eguiara; Arrate ; et al.	2010-04-08
Diagnostic method App 20100069334 - Cadaval; Ainara ; et al.	2010-03-18
Non-Invasive in Vitro Method to Detect Transitional Cell Carcinoma of the Bladder App 20090209431 - Villoch; Ana Soloaga ; et al.	2009-08-20
Methods And Products For In Vitro Genotyping App 20080070253 - SIMON BUELA; Laureano ; et al.	2008-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.